The current workforce pressures are leading to unplanned temporary closures that are beyond contractors’ control. In these circumstances, if contractors follow appropriate procedures to mitigate the effects of the closure on patients, the public, the NHS, and other community pharmacy contractors, they should avoid breaching their terms of service. The procedures – as well as
Read moreDrug alert number: EL(22)A/41 Date issued: 06 October 2022 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Stemetil 5mg/5ml Syrup PL 04425/0595 Batch Number Expiry Date Pack Size First Distributed 0032 Feb 2023 100ml 17 Sep 2020 0033 Aug 2023 100ml 26 May 2021 0034 Sep 2024
Read moreThe 2022 Community Pharmacy Workforce Survey, managed by Health Education England (HEE) has opened today. Completion of the survey is a mandatory requirement for all pharmacy contractors. The NHSBSA will, today, send an email to pharmacy contractors containing a link to the survey. In some cases, e.g. Company Chemists’ Association member companies and other larger
Read moreFurther details on the Pharmacy Quality Scheme (PQS) 2022/23 have today been published on the NHS Business Services Authority (NHSBSA) website. The details have been published as a separate Determination; they will be included in the Drug Tariff from November 2022. The PSNC PQS hub page has been updated to reflect the additional information that has
Read moreCommunity pharmacy contractors are reminded of the requirement to submit New Medicine Service (NMS) summary data to the NHS Business Services Authority (NHSBSA) within 10 working days from the last day of September 2022. Further information on the process to follow to submit NMS quarterly information can be found on the NHSBSA website. The
Read moreCommunity pharmacy contractors are reminded of the requirement to submit New Medicine Service (NMS) summary data to the NHS Business Services Authority (NHSBSA) within 10 working days from the last day of September 2022. Further information on the process to follow to submit NMS quarterly information can be found on the NHSBSA website. The
Read morePSNC is progressing work to enhance its negotiating capacity, strengthen its governance, develop a new vision and strategy for the sector, and more, in line with the Transforming Pharmacy Representation (TAPR) work programme. At its meeting in September, PSNC Members considered and voted on changes to the PSNC Constitution and to reduce the Committee size,
Read moreThe Department of Health and Social Care (DHSC) has today (03/10/2022) granted the following list of price concessions for September 2022: Drug Pack size Price concession Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream 30 £100.12 Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g ointment 30 £100.12 Liothyronine 5microgram tablets 28 £100.94 Sodium fusidate
Read moreCommunity pharmacy contractors who use NHS Profile Manager to update their pharmacy information are being invited by NHS Digital to test new service designs for the tool via a short 45-minute testing session. The testing sessions will be held via Microsoft Teams during the week commencing 10th October 2022. The sessions will be interactive, so
Read moreFollowing applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 14 new products will be classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 October 2022. This takes the total number of products granted DND status over the past
Read more
